RCMI Coordinating Center (RCMI CC) Header Logo

Thanigaivelan Kanagasabai

Concepts (80)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Thanigaivelan Kanagasabai's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Thanigaivelan Kanagasabai has written about over time.
Indoles, 1 publications between 2017 and 2017, average publication date November 2017. Pyridinium Compounds, 1 publications between 2017 and 2017, average publication date November 2017. Angiogenesis Inhibitors, 2 publications between 2017 and 2018, average publication date December 2017. Breast Neoplasms, 2 publications between 2017 and 2018, average publication date December 2017. Neovascularization, Pathologic, 2 publications between 2017 and 2018, average publication date December 2017. Vascular Endothelial Growth Factor Receptor-2, 2 publications between 2017 and 2018, average publication date December 2017. Adenocarcinoma, 1 publications between 2019 and 2019, average publication date November 2019. Imidazoles, 1 publications between 2019 and 2019, average publication date November 2019. Piperazines, 1 publications between 2019 and 2019, average publication date November 2019. Proto-Oncogene Proteins c-mdm2, 1 publications between 2019 and 2019, average publication date November 2019. Cell Proliferation, 5 publications between 2017 and 2024, average publication date August 2020. Cell Movement, 2 publications between 2017 and 2024, average publication date January 2021. Mice, 8 publications between 2017 and 2024, average publication date June 2021. Insulin Receptor Substrate Proteins, 1 publications between 2021 and 2021, average publication date October 2021. MicroRNAs, 1 publications between 2021 and 2021, average publication date October 2021. Sterol Regulatory Element Binding Protein 1, 1 publications between 2021 and 2021, average publication date October 2021. Prostatic Neoplasms, 5 publications between 2019 and 2024, average publication date January 2022. Jumonji Domain-Containing Histone Demethylases, 2 publications between 2020 and 2024, average publication date June 2022. Proto-Oncogene Proteins c-akt, 2 publications between 2020 and 2024, average publication date June 2022.

To see the data from this visualization as text, click here.
Kanagasabai's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (80)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support